Ibogaine News · Friday, July 31, 2026

Congressman Luttrell champions ibogaine for PTSD treatment

Luttrell's IBOGAINE Act aims to solidify psychedelic therapy access for veterans.

Congressman Luttrell has introduced the Initiating Biomedical Outcomes to Garner Advancements into Innovative Neuroplastogen Efficacy (IBOGAINE) Act, aiming to enhance access to ibogaine therapy for veterans suffering from PTSD. This legislative effort follows an executive order by former President Donald Trump to expedite psychedelic therapies for mental health issues, according to a report by Texas Insider.

What the study found

A study conducted by Stanford University School of Medicine in 2024 reported significant reductions in PTSD, depression, and anxiety symptoms among participants treated with ibogaine. Specifically, PTSD symptoms decreased by 88%, depression by 87%, and anxiety by 81% after just one month of treatment. These findings underscore the potential of ibogaine as a transformative therapy for mental health disorders, particularly among veterans, as highlighted by Congressman Luttrell.

Legislative context

The IBOGAINE Act is part of a broader legislative package, the National Defense Authorization Act (NDAA) for Fiscal Year 2027, which was recently passed by the House. This critical legislation not only supports national security but also promotes research into psychedelic-assisted treatments for severe mental health issues. The NDAA's passage in the Senate is anticipated, as it also includes provisions for advancing next-generation hypersonic weapons.

Why it matters

The introduction of the IBOGAINE Act represents a significant step toward addressing the mental health crisis among veterans. With veteran suicide rates remaining a critical concern, innovative treatments like ibogaine could offer a lifeline. Congressman Luttrell emphasizes the importance of making such advancements available to those who have served the nation, potentially improving their quality of life and readiness.

The NDAA's inclusion of ibogaine research highlights a growing recognition of psychedelic therapies' potential benefits, marking a shift in how mental health treatments are approached within the military context.

Reporting based on Texas Insider. Read the original: [link].

Sources

Reporting based on texasinsider.org. Read the original in the Sources section above.

Get the newsletter

Ibogaine news, in your inbox.

Occasional dispatches. No spam.